Clinical-stage medical technology company developing biodegradable polymers for unmet needs in vitreoretinal surgery
Clinical-stage medical technology company developing biodegradable polymers for unmet needs in vitreoretinal surgery. Its lead investigational product, PYK-2101, is an in situ cross-linking biodegradable hydrogel retinal sealant designed to support healing after retinal surgery while reducing recovery burdens such as facedown positioning and blurred vision.